SWTX
SpringWorks Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +14.5% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 2.92M | -2.8% | $128.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 2.58M | -21.1% | $113.98M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 1.72M | +2.7% | $75.72M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | D. E. Shaw & Co. ✦ | 1.66M | +329.0% | $73.41M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passive) | 833.50K | +346.9% | $36.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Duquesne Family Office ✦ | 615.93K | -28.4% | $27.18M | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 7 | Millennium Management ✦ | 503.87K | New | $22.24M | 0.0% | New | 1 | SEC ↗ |
| 8 | Soros Fund Management ✦ | 456.83K | -23.9% | $20.16M | 0.5% | ▼ Trim | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 251.51K | -32.6% | $11.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 185.90K | New | $8.20M | 0.0% | New | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 64.74K | +210.0% | $2.86M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 12 | Marshall Wace ✦ | 50.94K | New | $2.25M | 0.0% | New | 1 | SEC ↗ ×3 |
| 13 | Point72 Asset Management ✦ | 39.65K | New | $1.75M | 0.0% | New | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 30.56K | -2.0% | $1.35M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $22.24M | 0.0% |
| Renaissance Technologies | $8.20M | 0.0% |
| Marshall Wace | $2.25M | 0.0% |
| Point72 Asset Management | $1.75M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 1 shares, $47 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.